# Topical Timolol for Infantile Hemangioma in Early Proliferative Phase

> **NCT02731287** · PHASE2 · COMPLETED · sponsor: **Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau** · enrollment: 70 (actual)

## Conditions studied

- Hemangioma

## Interventions

- **DRUG:** Timolol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02731287
- **Lead sponsor:** Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2017-01
- **Final completion:** 2017-03
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2018-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02731287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02731287, "Topical Timolol for Infantile Hemangioma in Early Proliferative Phase". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02731287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*